Page last updated: 2024-08-23

bm 13505 and z 335

bm 13505 has been researched along with z 335 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Iwakuma, T; Kurimoto, T; Sato, H; Sato, R; Shinozaki, K; Yoshida, K1
Fukuda, Y; Fukuta, Y; Higashino, R; Ito, S; Kurimoto, T; Nomura, Y; Sato, R; Takei, M; Tamaki, H; Tanaka, T1

Other Studies

2 other study(ies) available for bm 13505 and z 335

ArticleYear
Synthesis and thromboxane A2 antagonistic activity activity of indane derivatives.
    Bioorganic & medicinal chemistry letters, 1999, Feb-08, Volume: 9, Issue:3

    Topics: Animals; Aorta; Indans; Muscle Contraction; Platelet Aggregation Inhibitors; Rabbits; Rats; Thromboxane A2

1999
Antiplatelet effect of Z-335, a new orally active and long-lasting thromboxane receptor antagonist.
    European journal of pharmacology, 1998, Sep-11, Volume: 357, Issue:1

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Biphenyl Compounds; Cilostazol; Drug Interactions; Fibrinolytic Agents; Guinea Pigs; Heptanoic Acids; Humans; Indans; Male; Mice; Mice, Inbred ICR; Phenylacetates; Platelet Aggregation; Platelet Aggregation Inhibitors; Pulmonary Embolism; Receptors, Thromboxane; Sulfonamides; Tetrazoles; Vasoconstrictor Agents

1998